A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study. The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium, or VRE, a superbug that frequently causes serious infections in hospitalised patients, according to an eight-year-longContinue Reading